Pfizer IncChange company Symbol lookupSelect an option...PFE Pfizer IncCIT CIT Group IncNXPI NXP Semiconductors NVPRTK Paratek Pharmaceuticals IncVTR Ventas IncGBIM Globeimmune IncSCKT Socket Mobile IncBK Bank of New York Mellon CorpBAC Bank of America CorpAACG ATA Creativity GlobalGo
Change company Symbol lookup
Select an option...
PFE Pfizer Inc
CIT CIT Group Inc
NXPI NXP Semiconductors NV
PRTK Paratek Pharmaceuticals Inc
VTR Ventas Inc
GBIM Globeimmune Inc
SCKT Socket Mobile Inc
BK Bank of New York Mellon Corp
BAC Bank of America Corp
AACG ATA Creativity Global
Health Care : Pharmaceuticals | Large Cap Value
Company profilePfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology, rare diseases and consumer healthcare. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. Its brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra.
|
|
|
|
| |
Latest Earnings (Q2 ending 06/2020)
- Q2 Non-GAAP earnings
GAAP vs. Non-GAAP Earnings
TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts.
- $0.78
- Q2 Consensus estimate
- $0.66
Latest Earnings Estimate Range
- Highest
estimate - $0.73
- Mean
estimate - $0.66
- Lowest
estimate - $0.55
Quarterly Consensus Estimates and Ranges
PFE's fiscal year ends in December
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.
Information provided by Copyright © 2020. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.